ADXN Stock Performance, Insider Transaction and News

ADXN - Addex Therapeutics Ltd

Market Cap	10.13M	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-9.7M	Forward P/E	-	EPS next Y	-	50D Avg Chg	-15.00%
Sales	863.23k	PEG	-	EPS past 5Y	-	200D Avg Chg	-39.00%
Dividend	N/A	Price/Book	1.38	EPS next 5Y	-	52W High Chg	-77.00%
Recommedations	2.00	Quick Ratio	4.67	Shares Outstanding	1.07M	52W Low Chg	26.00%
Insider Own	-	ROA	-49.87%	Shares Float	34.51M	Beta	-
Inst Own	0.29%	ROE	-103.35%	Shares Shorted/Prior	25.35K/1.03K	Price	0.53
Gross Margin	-	Profit Margin	500.17%	Avg. Volume	351,312	Target Price	30.17
Oper. Margin	-780.14%	Earnings Date	Nov 11	Volume	13,658	Change	-1.96%

Healthcare | Biotechnology | Switzerland

About Addex Therapeutics Ltd

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia and dystonia, and post-stroke/TBI recovery; ADX71149, a novel orally active metabotropic glutamate receptor subtype 2 positive allosteric modulator (mGlu2 PAM) for the treatment of epilepsy; and GABAB PAM for the treatment of pain, anxiety, overactive bladder, and addiction, as well as substance use disorder. Addex Therapeutics Ltd has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the discovery, development, and commercialization of novel mGlu2 PAM compounds for the treatment of CNS and related diseases; license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases; and The CharcotMarieTooth Association to evaluate the role of GABAB PAM compounds in preclinical models of CMT1A. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.

Addex Therapeutics Ltd News

11/11/24	Addex Provisional 2024 Third Quarter Results Showed Net Loss Compared to Second Quarter 2024
09/30/24	Addex Therapeutics Reports 2024 Half Year and Second Quarter Financial Results and Provides Corporate Update
09/19/24	Addex Provisional 2024 Half-Year and Second Quarter Result increased from a Net loss to a Net Profit
09/04/24	Addex to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
08/27/24	Addex and Indivior Select Clinical Candidates from GABAB Positive Allosteric Modulator Research Collaboration
07/22/24	Addex’s Partner Discontinues ADX71149 development in Epilepsy
07/15/24	Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International Cough Symposium (13th LICS)
07/12/24	Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
07/01/24	Addex Shareholders Approve All Resolutions at Annual General Meeting
06/06/24	Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
06/05/24	Addex Convenes Annual General Meeting 2024
05/31/24	Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
05/08/24	Addex to Present at Bio€quity Europe 2024
04/29/24	Addex Provides Update on ADX71149 Phase 2 Epilepsy Study
04/19/24	Addex to Present at the Swiss Biotech Day 2024
04/18/24	Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
04/11/24	Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024
04/03/24	Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders
03/14/24	Addex to Present at the Bio-Europe Spring 2024 Conference
01/31/24	Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.

ADXN Chatroom

PenkeTrading Posted - 15 hours ago

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Addex Therapeutics Ltd. Is that bullish or bearish? $ADXN #Addex #RsiOversold #NASDAQ

RodRosenstein Posted - 2 days ago

$ADXN Complete garbage.

frittenpit2019 Posted - 3 days ago

$ADXN The performance is cruel - I hate it.

R0tt3n Posted - 5 days ago

$ADXN tried to warn ya brother. Straight to 5 dollar land !

Roadsternh Posted - 1 week ago

$ADXN keep buying. They want it to go down but there’s no buyers. Without buyers they can’t cover. If we buy hard they will squeeze. :)

profitraider Posted - 1 week ago

$ADXN it’s over Boyz!

R0tt3n Posted - 1 week ago

$ADXN time for tankin.

BenKaitz Posted - 1 week ago

$ADXN bite the bullet and start reestablishing your position, baby boy.

KingNeptune Posted - 1 week ago

@MoeMoneyWiseGuy whoa! Was that really the Department of Health head? Ugh. Yes to $IBRX though. Grab some $ADXN and $ARVN with it. Bought these all around the same time. Ready for the pop.

Roadsternh Posted - 1 week ago

$ADXN no bids lol. how will they cover? they cant!

KingNeptune Posted - 2 weeks ago

$ADXN $CRBP looking good today. Nice to see

tradingtwenty Posted - 2 weeks ago

Top 5 stocks by smallest market cap that have trended in the past 24 hours: $NUWE 2.54M🔥 $YOSH 7.75M $PRPO 9.34M $ADXN 12.35M $NLSP 13.73M Link: https://tradingtwenty.com/dashboard/trending/past

R0tt3n Posted - 2 weeks ago

$ADXN garbage POS. Ready for $5

KingNeptune Posted - 10/28/24

$FDMT starting to gain some momentum again. Need $ADXN and $ARVN to start gaining to. Let's go!

Roadsternh Posted - 10/28/24

$ADXN will be at 30+ soon

GageyPies Posted - 10/24/24

$ADXN what is this

KingNeptune Posted - 10/24/24

@Scheissefinger hope lots of them. Digging $IBRX right now. Think I bought them the same time as $ADXN $MLTX $ARVN. Haven't been the home runs I expected yet, but all have it in them with time and PR. Slow and steady.